StonvexLoading…
StonvexCore line items from VIVO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $61.00K | $16.00K | $4.05M | $10.16M |
Operating Income | $-8.72M | $-8.52M | $-11.74M | $-14.90M |
Net Income | $-12.79M | $-46.70M | $-24.36M | $-22.05M |
EPS (Diluted) | $-1.92 | $-15.17 | $-9.87 | $-10.64 |
Total Assets | $97.13M | $37.43M | $61.42M | $69.66M |
Total Liabilities | $77.02M | $77.97M | $57.67M | $48.04M |
Cash & Equivalents | $60.00K | $199.00K | $553.00K | $1.28M |
Free Cash Flow OCF − CapEx | $-6.73M | $884.00K | $-6.47M | $-6.29M |
Shares Outstanding | Not available | Not available | Not available | Not available |